Cleveland Clinic Cancer Center investigators have published a body of research that may herald an era of improved staging and risk stratification for patients with Merkel cell carcinoma, utilizing distinct histologic patterns in sentinel lymph node biopsies.
Investigating Melanoma’s Molecular Driver Mutation Signature
Investigating tumor mutational burden, specific driver mutations, immune-related RNA expression data and various clinicopathologic features from 479 tumors to find correlations with clinical characteristics and outcomes.